Ani Pharmaceuticals (ANIP) Interest & Investment Income (2010 - 2013)
Ani Pharmaceuticals (ANIP) reported Interest & Investment Income of $1860.0 for Q1 2013, down 6.63% on a YoY basis from $1992.0 in Q1 2012, and down 42.57% sequentially from $3239.0 in Q4 2012.
Ani Pharmaceuticals (ANIP) Interest & Investment Income (2010 - 2013) Analysis & Trends
Ani Pharmaceuticals (ANIP) has 4 years of Interest & Investment Income data on file, last reported at $1860.0 in Q1 2013.
- For the quarter ending Q1 2013, Interest & Investment Income fell 6.63% year-over-year to $1860.0; the trailing twelve-month figure through Mar 2013 stood at $8407.0 (up 18.86% YoY), and the FY2012 full-year result was $8539.0, up 2.56% from the prior year.
- Interest & Investment Income slipped to $1860.0 in Q1 2013, from $3239.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $7199.0 in Q4 2010 to a low of $1431.0 in Q2 2012.
- A 4-year average of $2853.6 and a median of $1877.0 in 2012 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income slumped 74.25% in 2011 and surged 74.7% in 2012, its largest moves.
- Tracing ANIP's Interest & Investment Income over 4 years: stood at $7199.0 in 2010, then tumbled by 74.25% to $1854.0 in 2011, then surged by 74.7% to $3239.0 in 2012, then tumbled by 42.57% to $1860.0 in 2013.
- Business Quant data shows ANIP's Interest & Investment Income at $1860.0 in Q1 2013, $3239.0 in Q4 2012, and $1877.0 in Q3 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 32.85 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 41.80 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 28.10 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.33 Bn | 143.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 1,860.00 |
| Dec 31, 2012 | 3,239.00 |
| Sep 30, 2012 | 1,877.00 |
| Jun 30, 2012 | 1,431.00 |
| Mar 31, 2012 | 1,992.00 |
| Dec 31, 2011 | 1,854.00 |
| Sep 30, 2011 | 1,516.00 |
| Jun 30, 2011 | 1,711.00 |
| Mar 31, 2011 | 3,245.00 |
| Dec 31, 2010 | 7,199.00 |
| Sep 30, 2010 | 5,466.00 |